H.R. 2851 (105th): To prohibit application of a payment limit to a drug or biological under part B of the Medicare Program based on a less costly alternative for courses of treatment begun before the change in payment.
Nov 6, 1997
105th Congress, 1997–1998
Died in a previous Congress
This bill was introduced on November 6, 1997, in a previous session of Congress, but was not enacted.
Representative for Connecticut's 1st congressional district
Read Text »
Last Updated: Nov 6, 1997
Length: 3 pages
About the bill
- Summary (CRS)
- Provides that, if the Secretary of Health and Human Services or a carrier reduces a recognized rate for a drug or biological under part B (Supplementary Medical Insurance) of title ...
- What is a bill?
The “H.R.” in “H.R. 2851” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The bill’s title was written by its sponsor.
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no votes related to this bill.
- Subject Areas
- Find Similar Bills
Search for similar bills.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 2851 — 105th Congress: To prohibit application of a payment limit to a drug or biological under part B .... Retrieved from https://www.govtrack.us/congress/bills/105/hr2851
“H.R. 2851 — 105th Congress: To prohibit application of a payment limit to a drug or biological under part B ....” www.GovTrack.us. 1997. April 25, 2015 <https://www.govtrack.us/congress/bills/105/hr2851>
|title=H.R. 2851 (105th)
|accessdate=April 25, 2015
|author=105th Congress (1997)
|date=November 6, 1997
|quote=To prohibit application of a payment limit to a drug or biological under part B ...